Spontaneous Regression of an Epidermal Growth Factor Receptor-mutant Left Upper Lobe Adenocarcinoma

被引：0
|
作者：
Schiavon, Marco
Madrid, Andrea Lloret
Pezzuto, Federica
Giraudo, Chiara
Comacchio, Giovanni Maria
Faccioli, Eleonora
Dell'Amore, Andrea
Calabrese, Fiorella
Rea, Federico
机构：
[1] Padova Univ Hosp, Dept Cardiac Thorac Vasc Sci & Publ Hlth, Thorac Surg Div, Padua, Italy
[2] Padova Univ Hosp, Dept Cardiac Thorac Vasc Sci & Publ Hlth, Pathol Div, Padua, Italy
[3] Padova Univ Hosp, Radiol Inst, Dept Med, Padua, Italy
来源：
ANNALS OF THORACIC SURGERY | 2022年 / 114卷 / 04期
关键词：
CIPROFLOXACIN;
D O I：
10.1016/j.athoracsur.2021.11.064
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Spontaneous regression of cancer is a known mani-festation rarely described for thoracic malignancies. We present the case of a patient affected by an epidermal growth factor receptor-mutant adenocarci-noma who developed a contralateral aspiration pneu-monitis months before surgery and manifested a complete pathologic regression without any preopera-tive oncologic treatment. The underlying mechanisms are not clear, but immune system activation appears to be a key player, acting as a plausible trigger of a change in host response to cancer cells. The tumor microenvironment does not appear to be an "inert spectator" but rather an "active protagonist" on the course of the disease and its therapeutic targeting.(Ann Thorac Surg 2022;114:e261-e264) (c) 2022 by The Society of Thoracic Surgeons
引用
收藏
页码：E261 / E264
页数：4
相关论文
共 50 条
  • [21] Exome sequencing deciphers a germline MET mutation in familial epidermal growth factor receptor-mutant lung cancer
    Tode, Naoki
    Kikuchi, Toshiaki
    Sakakibara, Tomohiro
    Hirano, Taizou
    Inoue, Akira
    Ohkouchi, Shinya
    Tamada, Tsutomu
    Okazaki, Tatsuma
    Koarai, Akira
    Sugiura, Hisatoshi
    Niihori, Tetsuya
    Aoki, Yoko
    Nakayama, Keiko
    Matsumoto, Kunio
    Matsubara, Yoichi
    Yamamoto, Masayuki
    Watanabe, Akira
    Nukiwa, Toshihiro
    Ichinose, Masakazu
    CANCER SCIENCE, 2017, 108 (06): : 1263 - 1270
  • [22] Safety and Success of Repeat Lung Needle Biopsies in Patients with Epidermal Growth Factor Receptor-Mutant Lung Cancer
    Fintelmann, Florian J.
    Troschel, Fabian M.
    Kuklinski, Martin W.
    McDermott, Shaunagh
    Petranovic, Milena
    Digumarthy, Subba R.
    Sharma, Amita
    Troschel, Amelie S.
    Price, Melissa C.
    Hariri, Lida P.
    Gilman, Matthew D.
    Shepard, Joanne O.
    Sequist, Lecia V.
    Piotrowska, Zofia
    ONCOLOGIST, 2019, 24 (12): : 1570 - 1576
  • [23] A case of epidermal growth factor receptor-mutant lung cancer with transformation from adenocarcinoma into small cell carcinoma suggested by histological investigation of skin metastasis
    Omasa, Haruka
    Kakuta, Risa
    Terai, Hideki
    Kawaida, Miho
    Hirai, Ikuko
    Tamura, Kana
    Ito, Yoshihiro
    Fukushima-Nomura, Ayano
    Amagai, Masayuki
    Takahashi, Hayato
    JOURNAL OF DERMATOLOGY, 2025,
  • [24] Rare double mutations in epidermal growth factor receptor (EGFR) mutant adenocarcinoma of lung
    Jayaprakash, K. Thippu
    Yang, H.
    Aslam, S.
    Jeffs, Y.
    Jessop, S.
    Bulusu, V. R.
    LUNG CANCER, 2019, 127 : S92 - S93
  • [25] Cost Effectiveness of Gefitinib for Lung Adenocarcinoma Patients with Mutant Epidermal Growth Factor Receptor
    Hsia, T.
    Tu, C.
    Chen, H.
    Chen, S.
    Chen, C.
    Liao, W.
    Li, C.
    Lin, C.
    Li, C.
    Chien, C.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2127 - S2127
  • [26] Brain surgery for epidermal growth factor receptor-mutant non-small-cell lung cancer with brain metastases
    Lee, H. H.
    Huang, M-Y.
    ANNALS OF ONCOLOGY, 2018, 29 : 161 - 161
  • [27] Epithelial to Mesenchymal Transition in an Epidermal Growth Factor Receptor-Mutant Lung Cancer Cell Line with Acquired Resistance to Erlotinib
    Suda, Kenichi
    Tomizawa, Kenji
    Fujii, Makiko
    Murakami, Hideki
    Osada, Hirotaka
    Maehara, Yoshihiko
    Yatabe, Yasushi
    Sekido, Yoshitaka
    Mitsudomi, Tetsuya
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (07) : 1152 - 1161
  • [28] Successful Dasatinib Treatment of Epidermal Growth Factor Receptor-Mutant Lung Adenocarcinoma and BCR-ABL1-Positive Chronic Myeloid Leukemia: A Case Report
    Tsukaguchi, Akihiro
    Minami, Seigo
    Yasuoka, Hironao
    Kin, Yoshihiro
    CASE REPORTS IN ONCOLOGY, 2022, 15 (03): : 1081 - 1087
  • [29] Furmonertinib re-challenge for epidermal growth factor receptor-mutant lung adenocarcinoma after osimertinib-induced interstitial lung disease: A case report
    Wei, Fei-Fei
    Zhang, Jing
    Jia, Zhe
    Yao, Zhi-Chao
    Chen, Chun-Qiao
    WORLD JOURNAL OF CLINICAL ONCOLOGY, 2025, 16 (03):
  • [30] Epidermal Growth Factor Receptor-Mutant Lung Cancer New Drugs, New Resistance Mechanisms, and Future Treatment Options
    Piotrowska, Zofia
    Sequist, Lecia V.
    CANCER JOURNAL, 2015, 21 (05): : 371 - 377
12345